Dynamic contour tonometer and Goldmann applanation tonometer performance in a developing world setting: intraocular pressure measurement acquisition and precision.

PURPOSE: To examine tonometer usability and intraocular pressure (IOP) measurement precision in a general ophthalmology clinic in the developing world. METHODS: A total of 100 eyes of 100 participants attending a charity ophthalmology walk-in clinic in Ghana, West Africa, had IOP measurements made with the Goldmann applanation tonometer (GAT) and the dynamic contour tonometer (DCT) in a randomized order by 2 clinicians. Both clinicians had extensive experience in using the GAT but were relatively inexperienced in using the DCT. The repeatability coefficient was calculated to determine intraobserver variability. Reproducibility of interobserver IOP measurements was calculated using Bland-Altman analysis. RESULTS: IOP could not be measured in 3% of eyes using the GAT and in 16% of eyes using the DCT. The repeatability coefficient for the GAT and DCT were 2.5 and 3.0 mm Hg, respectively. The DCT repeatability coefficient was 2.3 mm Hg when only "good quality" measurements were considered. The interobserver mean difference (limits of agreement) were -0.8 mm Hg (±3.9 mm Hg) for the GAT and 0.3 mm Hg (±3.3 mm Hg) for the DCT. DCT IOP measurements were unobtainable in eyes with corneal surface irregularities or excessive eye or lid movements. CONCLUSIONS: The DCT shows good measurement precision with comparable repeatability and superior reproducibility compared with the GAT. The DCT score is useful in its objectivity and improving repeatability. However, patient and ocular surface factors may impede DCT measurements, impacting upon its general usability in a high volume, walk-in community clinic.

Automated multidetector row CT dataset segmentation with an interactive watershed transform (IWT) algorithm: Part 2. Body CT angiographic and orthopedic applications.

The preceding manuscript describes the principles behind the Interactive Watershed Transform (IWT) segmentation tool. The purpose of this manuscript is to illustrate the clinical utility of this editing technique for body multidetector row computed tomography (MDCT) imaging. A series of cases demonstrates clinical applications where automated segmentation of skeletal structures with IWT is most useful. Both CT angiography and orthopedic applications are presented.

Automated multidetector row CT dataset segmentation with an interactive watershed transform (IWT) algorithm: Part 1. Understanding the IWT technique.

Segmentation of volumetric computed tomography (CT) datasets facilitates evaluation of 3D CT angiography renderings, particularly with maximum intensity projection displays. This manuscript describes a novel automated bone editing program that uses an interactive watershed transform (IWT) technique to rapidly extract the skeletal structures from the volume. Advantages of this tool include efficient segmentation of large datasets with minimal need for correction. In the first of this two-part series, the principles of the IWT technique are reviewed, followed by a discussion of clinical utility based on our experience.

Volume rendering versus maximum intensity projection in CT angiography: what works best, when, and why.

The introduction and widespread availability of 16-section multi-detector row computed tomographic (CT) technology and, more recently, 64-section scanners, has greatly advanced the role of CT angiography in clinical practice. CT angiography has become a key component of state-of-the-art imaging, with applications ranging from oncology (eg, staging of pancreatic or renal cancer) to classic vascular imaging (eg, evaluation of aortic aneurysms and renal artery stenoses) as well as newer techniques such as coronary artery imaging and peripheral runoff studies. With an average of 400-1000 images in each volume data set, three-dimensional postprocessing is crucial to volume visualization. Radiologists now have workstations that provide capabilities for evaluation of these data sets by using a range of software programs and processing tools. Although different systems have unique capabilities and functionality, all provide the options of volume rendering and maximum intensity projection for image display and analysis. These two postprocessing techniques have different advantages and disadvantages when used in clinical practice, and it is important that radiologists understand when and how each technique should be used.

Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague.

A two-component recombinant fusion protein antigen was re-engineered and tested as a medical counter measure against the possible biological threat of aerosolized Yersinia pestis. The active component of the proposed subunit vaccine combines the F1 capsular protein and V virulence antigen of Y. pestis and improves upon the design of an earlier histidine-tagged fusion protein. In the current study, different production strains were screened for suitable expression and a purification process was optimized to isolate an F1-V fusion protein absent extraneous coding sequences. Soluble F1-V protein was isolated to 99% purity by sequential liquid chromatography including capture and refolding of urea-denatured protein via anion exchange, followed by hydrophobic interaction, concentration, and then transfer into buffered saline for direct use after frozen storage. Protein identity and primary structure were verified by mass spectrometry and Edman sequencing, confirming a purified product of 477 amino acids and removal of the N-terminal methionine. Purity, quality, and higher-order structure were compared between lots using RP-HPLC, intrinsic fluorescence, CD spectroscopy, and multi-angle light scattering spectroscopy, all of which indicated a consistent and properly folded product. As formulated with aluminum hydroxide adjuvant and administered in a single subcutaneous dose, this new F1-V protein also protected mice from wild-type and non-encapsulated Y. pestis challenge strains, modeling prophylaxis against pneumonic and bubonic plague. These findings confirm that the fusion protein architecture provides superior protection over the former licensed product, establish a foundation from which to create a robust production process, and set forth assays for the development of F1-V as the active pharmaceutical ingredient of the next plague vaccine.

Direct comparison of the BD ProbeTec ET system with in-house LightCycler PCR assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae from clinical specimens.

The commercial BD ProbeTec ET (BDPT) system for the detection of Neisseria gonorrhoeae and Chlamydia trachomatis from clinical specimens was compared with our in-house LightCycler real-time PCR (LC-PCR) assays. Specimens initially positive by the BDPT system were retested by our LC-PCR assays. Our results for C. trachomatis testing indicate a 91.2% agreement when the results of 114 clinical specimens, initially positive by BDPT over a wide range of method-other-than-acceleration (MOTA) scores, were retested by our LC-PCR assay. The agreement between the two systems improved to 96% when only MOTA scores of >30,000 were retested by the LC-PCR assay. The overall agreement between the two systems for Neisseria gonorrhoeae detection from 155 clinical specimens was only 77.4%, with agreement particularly low (24.1%) for MOTA scores ranging from 2,000 to 19,999. Repeat testing of specimens with the BDPT only closely correlated with that seen by others demonstrating that reproducibility of the BDPT system for specimens initially within the MOTA score range from 2,000 to 9,999 is problematic, especially for Neisseria gonorrhoeae testing. With our study, we proposed an algorithm for C. trachomatis and N. gonorrhoeae testing which involves screening with the BDPT system followed by selective use of our in-house LC-PCR assays.

Multidetector-row computed tomography with three-dimensional volume rendering of pancreatic cancer: a complete preoperative staging tool using computed tomography angiography and volume-rendered cholangiopancreatography.

Volume rendering, a postprocessing computer algorithm that creates three-dimensional (3D) displays from computed tomography (CT) datasets, can create 3D cholangiographic images (volume-rendered cholangiopancreatography, or VRCP) from intravenous contrast-enhanced abdominal CT datasets without the use of a biliary contrast agent. This article illustrates the utility of VRCP in the setting of biliary obstruction due to pancreatic cancer. The 3D renderings of the intra- and extrahepatic biliary tree provide valuable information for planning biliary drainage, including the location and length of the obstruction as well as the relationship of intrahepatic ducts to liver metastases.

Six-year molecular analysis of Burkholderia cepacia complex isolates among cystic fibrosis patients at a referral center for lung transplantation.

Over a 6-year period, Burkholderia cepacia complex species were isolated from cystic fibrosis (CF) patients receiving care at The University of North Carolina Hospitals (clinic CF patients) and from those referred from other treatment centers. Fifty-six isolates collected from 30 referred patients and 26 clinic CF patients were characterized by pulsed-field gel electrophoresis (PFGE) and were assayed by PCR to detect the cable pilin gene, cblA. PFGE results indicated that six separate clusters (clusters A to F) were present among the 56 isolates and that three clusters (clusters A, B, and E) consisted only of isolates from referred patients infected with B. cepacia complex isolates prior to referral. However, one cluster (cluster C) consisted of isolates from four CF patients, and hospital records indicate that this cluster began with an isolate that came from a referred patient and that spread to three clinic CF patients. Cluster D consisted of two isolates from clinic CF patients, and hospitalization records are consistent with nosocomial, patient-to-patient spread. cblA was present in only 4 of the 56 isolates and included isolates in cluster E from the referred patients. Our results indicate a lack of spread of a previously characterized, transmissible clone from referred patients to our clinic CF population. Only two instances of nosocomial, patient-to-patient spread could be documented over the 6-year period. An additional spread of an isolate (cluster F) from a referred patient to a clinic patient could not be documented as nosocomial and may have been the result of spread in a nonhospitalized setting. The majority (36 of 56) of our B. cepacia complex-infected CF patients harbor isolates with unique genotypes, indicating that a diversity of sources account for infection. These data suggest that CF patients infected with B. cepacia complex and referred for lung transplantation evaluation were not a major source of B. cepacia complex strains that infected our resident CF clinic population.